mechanism of action of bpc-157 Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts BPC 157 and TB 500:

Mg Units (40 mg vial + 2.0 mL BAC water = 20 mg/mL) Weekly dose 2.5 mg Volume 0.125 mL U-100 syringe units 12.5 units Weekly dose 5 mg Volume 0.25 mL U-100 syringe units 25 units Weekly dose 7.5 mg Volume 0.375 mL U-100 syringe units 37.5 units Weekly dose 10 mg Volume 0.50 mL U-100 syringe units 50 units Weekly dose 12.5 mg Volume 0.625 mL U-100 syringe units 62.5 units Weekly dose 15 mg Volume 0.75 mL U-100 syringe units 75 units On a 0.5 mL / 50-unit syringe, 12.5 mg and 15 mg need a larger syringe

On the other hand, VIP peptide plays a role in supporting tissue repair and healing through its anti-inflammatory properties and modulation of immune responses

Evidence for Use in Arthritis or Orthopedic Conditions Bottom line: there is no high-quality evidence that BPC-157 helps arthritis in humans

Standard laboratory practices apply, including sterile preparation, controlled storage, and proper disposal in accordance with safety guidelines